Company Partnering Publications Contact Sitemap Home
   PULMONARY    NASAL
DirectHaler™ Pulmonary
Proven clinical performance
Learn how the device can be so simple
Confirmed acceptability world-wide
Wide range of customisation options
Unique manufacturability
Applications for DirectHaler Pulmonary
DirectHaler™ Pulmonary

DirectHaler™ Pulmonary is an innovative and new device for dry powder intrapulmonary delivery. The most advanced clinical programmes have completed Phase II/III.

Each pre-metered, pre-filled pulmonary dose has its own DirectHaler™ Pulmonary device. The device is hygienically disposable and is made of only 0,6 grammes of Polypropylene. DirectHaler™ Pulmonary offers effective, accurate and repeatable dosing in an intuitively easy-to-use device format.

DirectHaler™ Pulmonary Inhalator - an innovation in dry powder delivery


DirectHaler™ Pulmonary opens a new track of development in pulmonary delivery

  • Pre-metered and pre-filled dose; No risk of double dosing
  • Visual confirmation; dose “ready” – dose “taken”
  • Reliable – no mechanically moving parts
  • Cost-effective (manufacture, filling & assembly)
  • Hygienic – single-use disposable.
  • Discrete in use
  • Portable - compact size
  • Ideal for therapy applications “Once-daily”, “Once-a-few-times” or “Once-only”.
  • Protected by issued patents world-wide
  • Proven performance and acceptability

Please "click" for each section with detailed information...

Documented performance in Phase I and II/III clinical trials and in-vitro characterisation studies. Read more>>



Sofisticated fluid dynamic principles in the dispersion and gradual entrainment of the powder dose into the airstream. Read more>>



Documented acceptability in USA, Europe and India. Among pulmonologists, General Practioners instruction nurses and patients. Read more>>



Cost-effective manufacture, filling and assembly by proven mass production technologies. Unique supply-chain flexibility. Read more>>



Unique device customization options: protection of sensitive powders, deep lung delivery, high drug payloads, and combination therapy. Read more>>